Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Campaigns were Conducted against the Ministry because of its Minister's Stances; some Dossiers were Excluded from the Cabinet's Agenda

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani stressed that false information has been circulated concerning the financial ceilings and the performance of the Lebanese Forces ministers was criticized, while these latter ministers have proved to be an example that should be followed in the government.  

Hasbani was quoted as saying by the state-run Tele Liban the financial prosecutor heard Tuesday two counselors who were found innocent. “We respect any judicial decision taken and the allegations and what was said about us were found to be wrong,” Hasbani added.

The financial ceilings

Hasbani explained the issue of the financial ceilings saying that in the previous years no mechanism was adopted for these ceilings which were set without clear standards. “We have adopted a mechanism based on the size of the hospital, the real number of beds, the services provided and the cost of bed. We found out that the declared number of beds in the syndicate was incorrect. The head of the association was informed and we adopted the existing number of beds in each hospital.”

“The mechanism for the financial ceilings that we have submitted to the cabinet since 2017 was not included in the agenda. Therefore, we referred to the powers stipulated in the law that give the minister the right to amend the financial ceilings as needed,” the Minister of Public Health added.

No shortage in drugs

As for drug shortages, Hasbani noted that there was no lack of free drugs in Quarantine and all what has been circulated was not true. There are many drugs of which prices were cut off according to a specific mechanism.

“The drugs available in the Lebanese markets are from all the countries and abide by all mechanisms and conditions. 25 thousand patients benefit from the drugs provided by the Ministry of Public Health,” Hasbani added.

The Ministry of Public Health conducts permanent awareness campaigns to prevent diseases. An awareness campaign on obesity will be launched soon, knowing that these campaigns receive technical and financial support from the World Health Organization and the World Bank respectively.
 
Food Safety


Hasbani tackled food safety saying that the Ministry of Public Health conducted 29 thousand inspections and issued 10 thousand warnings. “We have never heard about them in the media because they tarnish the reputation of the Lebanese food sector. We have also launched the Application “Ballegh Lel Soha” that enables the citizens to report to the ministry on any violation,” Hasbani noted
    5
    ...
ATC Name B/G Ingredients Dosage Form Price
L01EF01 PALBRANCE 100 G Palbociclib - 100mg 100mg Capsule 168,011,222 L.L
L01EF01 PAPILLIO G Palbociclib - 100mg 100mg Capsule, hard 147,883,080 L.L
M01AE03 PROFENID B Ketoprofen - 100mg 100mg Tablet, film coated 469,001 L.L
M01AE03 PROFENID B Ketoprofen - 100mg 100mg Suppository 321,178 L.L
N06AB06 PMS-SERTRALINE G Sertraline HCl - 100mg 100mg Capsule 2,015,764 L.L
L01BA04 PEMETREXED NEAPOLIS G Pemetrexed (disodium) - 100mg 100mg Injectable solution 10,554,169 L.L
J02AC01 PANZIMOL G Fluconazole - 100mg 100mg Capsule, hard 1,988,887 L.L
N04BB01 PK-MERZ B Amantadine (sulfate) - 100mg 100mg Tablet, film coated 1,382,814 L.L
G03DA04 PROGEST G Progesterone micronised - 100mg 100mg Capsule, soft gelatin 368,213 L.L
G03DA04 PROGEST G Progesterone micronised - 100mg 100mg Capsule, soft gelatin 368,213 L.L
L01CD01 PACLITAXEL MYLAN PHARMA 6MG/ML G Paclitaxel - 100mg/16.7ml 100mg/16.7ml Injectable concentrated powder for solution 22,410,062 L.L
L01CD01 PANATAXEL G Paclitaxel - 100mg/16.7ml 100mg/16.7ml Injectable concentrated solution 7,071,670 L.L
L01CD01 PATAXEL G Paclitaxel - 100mg/16.7ml 100mg/16.7ml Injectable concentrate for solution 8,500,054 L.L
L01CD01 PANATAXEL G Paclitaxel - 100mg/16.7ml 100mg/16.7ml Injectable concentrated solution L.L
G03DA04 PROGESING BioTech Progesterone - 100mg/2ml 100mg/2ml Injectable oily solution 1,423,129 L.L
L01BA04 PEMETREXED EVER PHARMA G Pemetrexed (disodium) - 100mg/4ml 100mg/4ml Injectable concentrate for solution 12,185,492 L.L
L01BA04 PEMETREXED STRAGEN G Pemetrexed (disodium) - 100mg/4ml 100mg/4ml Injectable concentrate for solution 12,759,187 L.L
M01AE01 PEDIAFEN G Ibuprofen - 100mg/5ml 100mg/5ml Suspension 200,936 L.L
M01AE01 PROFINAL G Ibuprofen - 100mg/5ml 100mg/5ml Suspension 208,296 L.L
A10AB04 PROLOG BioTech Insulin lispro - 100U/ml 100U/ml Injectable solution 637,365 L.L
A10AB04 PROLOG BioTech Insulin lispro - 100U/ml 100U/ml Injectable solution 2,126,343 L.L
A10AB04 PROLOG BioTech Insulin lispro - 100U/ml 100U/ml Injectable solution 883,480 L.L
A10AB04 PROLOG BioTech Insulin lispro - 100U/ml 100U/ml Injectable suspension 1,503,312 L.L
B05XA01 POTASSIUM CHLORIDE G Potassium chloride - 10g/100ml 10g/100ml Injectable solution 3,023,493 L.L
N05AH03 PRANZA G Olanzapine - 10mg 10mg Tablet, orodispersible 3,553,120 L.L
N05AH03 PREXAL 10 G Olanzapine - 10mg 10mg Caplet, film coated 881,561 L.L
C10AA07 PMS-ROSUVASTATIN G Rosuvastatin (calcium) - 10mg 10mg Tablet 564,414 L.L
N05AX12 PIRIFY G Aripiprazole - 10mg 10mg Tablet 795,555 L.L
G04CA01 PROSTETROL G Alfuzosin HCl - 10mg 10mg Tablet, modified release 360,150 L.L
C07AA05 PROBETOL G Propranolol HCl - 10mg 10mg Tablet 126,705 L.L
    5
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026